NCT03807492Completed
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine rates of genetic mutations among men with or at-risk for prostate cancer to address the various facets of genetic education and counseling for optimized genetic assessment and wellness of men. The results will inform practice guidelines and future studies for maximal impact of genetic evaluation of men for inherited prostate cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 241 (actual)
- First submitted
- 21 Dec 2018
- Start date
- 16 Jan 2019
- Primary completion date
- 1 Jun 2022
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Diseases
- Prostate cancer
- NCT number
- NCT03807492
What you commit to
- Study type: Observational
- Participants enrolled: 241
- From 16 Jan 2019 to the primary completion date, 1 Jun 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Mental or cognitive impairment that interferes with ability to provide informed consent
Age
- Age \< 18 years
Who the study is looking for
- Men with a personal history of prostate cancer
- Unaffected males who are at higher risk for prostate cancer (family history of prostate cancer or African American males)
- Men who previously tested positive for a mutation may be eligible for Specific Aims 2-7
- Men with a known familial mutation
- Men who previously participated in the Genetic Evaluation of Men (GEM) study (IRB#14S.546) will be offered participation in EMPOWeR -
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thomas Jefferson University Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.